» Articles » PMID: 25979339

Trans-regulation of Syndecan Functions by Hetero-oligomerization

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2015 May 17
PMID 25979339
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Syndecans, a family of transmembrane heparansulfate proteoglycans, are known to interact through their transmembrane domains to form non-covalently linked homodimers, a process essential for their individual functions. Because all syndecan transmembrane domains are highly conserved and thus might mediate interactions between different members of the syndecan family, we investigated syndecan interactions in detail. All recombinant syndecan-2 and -4 protein variants containing the transmembrane domain formed not only sodium dodecyl sulfate (SDS)-resistant homodimers but also SDS-resistant heterodimers. Biochemical and structural data revealed that recombinant syndecan-2 and -4 formed intermolecular interactions in vitro, and the GXXXG motif in transmembrane domain mediated this interaction. When exogenously expressed in rat embryonic fibroblasts, syndecan-2 interacted with syndecan-4 and vice versa. Furthermore, bimolecular fluorescence complementation-based assay demonstrated specific hetero-molecular interactions between syndecan-2 and -4, supporting hetero-oligomer formation of syndecans in vivo. Interestingly, hetero-oligomerization significantly reduced syndecan-4-mediated cellular processes such as protein kinase Cα activation and protein kinase Cα-mediated cell adhesion as well as syndecan-2-mediated tumorigenic activities in colon cancer cells such as migration and anchorage-independent growth. Taken together, these data provide evidence that hetero-oligomerization produces distinct syndecan functions and offer insights into the underlying signaling mechanisms of syndecans.

Citing Articles

Characterization of wooden breast myopathy: a focus on syndecans and ECM remodeling.

Pejskova L, Ronning S, Kent M, Solberg N, Host V, Thu-Hien T Front Physiol. 2023; 14:1301804.

PMID: 38130476 PMC: 10737271. DOI: 10.3389/fphys.2023.1301804.


Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression.

Beauvais D, Nelson S, Adams K, Stueven N, Jung O, Rapraeger A J Biol Chem. 2022; 298(6):102029.

PMID: 35569509 PMC: 9190016. DOI: 10.1016/j.jbc.2022.102029.


Extended disorder at the cell surface: The conformational landscape of the ectodomains of syndecans.

Gondelaud F, Bouakil M, Le Fevre A, Miele A, Chirot F, Duclos B Matrix Biol Plus. 2021; 12:100081.

PMID: 34505054 PMC: 8416954. DOI: 10.1016/j.mbplus.2021.100081.


Syndecan Transmembrane Domain Specifically Regulates Downstream Signaling Events of the Transmembrane Receptor Cytoplasmic Domain.

Hwang J, Jang B, Kim A, Lee Y, Lee J, Kim C Int J Mol Sci. 2021; 22(15).

PMID: 34360683 PMC: 8347082. DOI: 10.3390/ijms22157918.


Syndecan-1 (CD138), Carcinomas and EMT.

Couchman J Int J Mol Sci. 2021; 22(8).

PMID: 33921767 PMC: 8072910. DOI: 10.3390/ijms22084227.


References
1.
Langan E, Youkey J, Showalter L, Carey D . Syndecan-4 is a primary-response gene induced by basic fibroblast growth factor and arterial injury in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1997; 17(1):172-80. DOI: 10.1161/01.atv.17.1.172. View

2.
Cohen B, Green J, Foy L, Fell H . HER4-mediated biological and biochemical properties in NIH 3T3 cells. Evidence for HER1-HER4 heterodimers. J Biol Chem. 1996; 271(9):4813-8. DOI: 10.1074/jbc.271.9.4813. View

3.
Oh E, Woods A, Couchman J . Multimerization of the cytoplasmic domain of syndecan-4 is required for its ability to activate protein kinase C. J Biol Chem. 1997; 272(18):11805-11. DOI: 10.1074/jbc.272.18.11805. View

4.
Carey D . Syndecans: multifunctional cell-surface co-receptors. Biochem J. 1997; 327 ( Pt 1):1-16. PMC: 1218755. DOI: 10.1042/bj3270001. View

5.
Horowitz A, Simons M . Regulation of syndecan-4 phosphorylation in vivo. J Biol Chem. 1998; 273(18):10914-8. DOI: 10.1074/jbc.273.18.10914. View